As Dylan pointed out, it is extremely difficult to get through clinical trials and become approved.
YK11 is one of the most popular sarms on the market so if it were not extremely effective that would just not be possible
YK11 is one of the most popular sarms on the market so if it were not extremely effective that would just not be possible